VGLSOTC MarketsView live quote
Investor Relations — ir@biomolecularlifeinc.com
Biomolecular LifeBiomolecular LifeInc. · VGLS
Investor Relations

Investors & Newsroom

Biomolecular Life, Inc. is positioned at the intersection of longevity science, advanced wellness technology, precision nutrition, and premium consumer health. This is the company's hub for stock information, filings, and press releases.

VGLSTrading symbol
OTCOTC Markets
BIOLBiomolecular Life brand
Dec 31Fiscal year end

Live price and chart provided by TradingView. Quotes for OTC securities may be delayed.

Newsroom

Press Releases

Official company announcements. Entries below are placeholders — replace each with your issued release and link to the full text.

Filings & Disclosure

SEC & OTC Filings

All company filings can be verified directly with the regulators and OTC Markets. The links below are live. Historical SEC filings appear under the issuer's prior corporate names.

Recent Filings · Live from SEC EDGAR

Investment Highlights

The case for Biomolecular Life

01

Longevity economy exposure

Operating across longevity, personalized wellness, nutraceuticals, preventive healthcare, wellness technology, and companion-animal health.

02

Integrated ecosystem

Proprietary wellness technology paired with premium nutraceuticals in one optimization platform.

03

Human & pet portfolio

A dual market spanning people and the companion animals they love.

04

Scalable model

Clinic, licensing, and international distribution opportunities for proprietary technology and products.

05

Premium positioning

Luxury wellness brand targeting the high end of a rapidly growing market.

06

R&D pipeline

Next-generation biomolecular therapies and AI-powered health-optimization platforms.

Investor Relations

Contact Investor Relations

For investor inquiries, filings questions, and partnership opportunities.

ir@biomolecularlifeinc.com